A new study has found that women may safely take the anti-AIDS drug nevirapine during pregnancy for the purpose of protecting unborn children from HIV AIDS transmission through the mother. The study, published in the New England Journal of Medicine in January 2007, found that nevirapine will not threaten the health of pregnant women or the effectiveness of life-saving AIDS drug treatment if postponed while using nevirapine.
While nevirapine is associated with certain health risks such as liver poison and rashes, this is only the case in prolonged use. The study has shown that short doses of nevirapine followed by combination drugs six months later is an effective anti-AIDS treatment for both a pregnant woman and her child.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment